Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.

  • Beutler B
  • Milsark I
  • Cerami A
671Citations
Citations of this article
69Readers
Mendeley users who have this article in their library.

Abstract

A highly specific radioreceptor assay for cachectin/tumor necrosis factor (TNF) was utilized to measure the time course of lipopolysaccharide (LPS)-induced hormone production in rabbits. Cachectin/TNF bioactivity was monitored in the same serum samples by measuring lipoprotein lipase (LPL) suppression in 3T3-L1 cells. Cachectin/TNF is produced in large quantities by LPS-treated rabbits without priming by bacillus Calmette Guérin, C. parvum, or other agents. Nanomolar concentrations of the hormone are achieved, with peak levels occurring at 2 hr postinjection; the hormone is rapidly cleared thereafter. In separate studies, mice were used to assess the distribution and metabolic fate of cachectin/TNF. Radioiodinated hormone is cleared from the plasma with a half-life of 6 to 7 min. Studies of the tissue distribution of label after injection demonstrate that liver, kidneys, skin, and gastrointestinal tract take up most of the hormone. Electrophoretic analysis of tissues recovered from injected animals suggests that the hormone is very rapidly degraded after binding.

Cite

CITATION STYLE

APA

Beutler, B. A., Milsark, I. W., & Cerami, A. (1985). Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. The Journal of Immunology, 135(6), 3972–3977. https://doi.org/10.4049/jimmunol.135.6.3972

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free